Zhu YH - Search Results

1

Current RNA-based Therapeutics in Clinical Trials.

Zhou LY, Qin Z, Zhu YH, He ZY, Xu T. Zhou LY, et al. Among authors: zhu yh. Curr Gene Ther. 2019;19(3):172-196. doi: 10.2174/1566523219666190719100526. Curr Gene Ther. 2019. PMID: 31566126 Review.

2

Progress in the treatment of infantile hemangioma.

Chen ZY, Wang QN, Zhu YH, Zhou LY, Xu T, He ZY, Yang Y. Chen ZY, et al. Among authors: zhu yh. Ann Transl Med. 2019 Nov;7(22):692. doi: 10.21037/atm.2019.10.47. Ann Transl Med. 2019. PMID: 31930093 Free PMC article. Review.

3

Novel zwitterionic vectors: Multi-functional delivery systems for therapeutic genes and drugs.

Zhou LY, Zhu YH, Wang XY, Shen C, Wei XW, Xu T, He ZY. Zhou LY, et al. Among authors: zhu yh. Comput Struct Biotechnol J. 2020 Jul 25;18:1980-1999. doi: 10.1016/j.csbj.2020.07.015. eCollection 2020. Comput Struct Biotechnol J. 2020. PMID: 32802271 Free PMC article. Review.

4

Association Between Genetic Polymorphisms of Metabolic Enzymes and Azathioprine-Induced Myelosuppression in 1,419 Chinese Patients: A Retrospective Study.

Chen ZY, Zhu YH, Zhou LY, Shi WQ, Qin Z, Wu B, Yan Y, Pei YW, Chao NN, Zhang R, Wang MY, Su ZH, Lu XJ, He ZY, Xu T. Chen ZY, et al. Among authors: zhu yh. Front Pharmacol. 2021 May 18;12:672769. doi: 10.3389/fphar.2021.672769. eCollection 2021. Front Pharmacol. 2021. PMID: 34084143 Free PMC article.

5

Anlotinib Suppressed Ovarian Cancer Progression via Inducing G2/M Phase Arrest and Apoptosis.

Zhu Y, Wang X, Chen Z, Zhou L, Di X, Fan P, He Z. Zhu Y, et al. J Clin Med. 2022 Dec 25;12(1):162. doi: 10.3390/jcm12010162. J Clin Med. 2022. PMID: 36614964 Free PMC article.

6

Duchenne muscular dystrophy treatment with lentiviral vector containing mini-dystrophin gene in vivo.

Wang X, Zhu Y, Liu T, Zhou L, Fu Y, Zhao J, Li Y, Zheng Y, Yang X, Di X, Yang Y, He Z. Wang X, et al. MedComm (2020). 2024 Jan 6;5(1):e423. doi: 10.1002/mco2.423. eCollection 2024 Jan. MedComm (2020). 2024. PMID: 38188603 Free PMC article.

7

The multiple roles of interferon regulatory factor family in health and disease.

Wang L, Zhu Y, Zhang N, Xian Y, Tang Y, Ye J, Reza F, He G, Wen X, Jiang X. Wang L, et al. Signal Transduct Target Ther. 2024 Oct 9;9(1):282. doi: 10.1038/s41392-024-01980-4. Signal Transduct Target Ther. 2024. PMID: 39384770 Free PMC article. Review.

8

Targeting autophagy and beyond: Deconvoluting the complexity of Beclin-1 from biological function to cancer therapy.

Ye J, Zhang J, Zhu Y, Wang L, Jiang X, Liu B, He G. Ye J, et al. Acta Pharm Sin B. 2023 Dec;13(12):4688-4714. doi: 10.1016/j.apsb.2023.08.008. Epub 2023 Aug 12. Acta Pharm Sin B. 2023. PMID: 38045051 Free PMC article. Review.

9

Mechanisms of PANoptosis and relevant small-molecule compounds for fighting diseases.

Wang L, Zhu Y, Zhang L, Guo L, Wang X, Pan Z, Jiang X, Wu F, He G. Wang L, et al. Cell Death Dis. 2023 Dec 21;14(12):851. doi: 10.1038/s41419-023-06370-2. Cell Death Dis. 2023. PMID: 38129399 Free PMC article. Review.

10

A hierarchically acidity-unlocking nanoSTING stimulant enables cascaded STING activation for potent innate and adaptive antitumor immunity.

Zhu S, He T, Wang Y, Ma Y, Li W, Gong S, Zhu Y, Wang X, Xu X, Wu Q, Gong C, You Y. Zhu S, et al. Theranostics. 2024 Sep 16;14(15):5984-5998. doi: 10.7150/thno.98272. eCollection 2024. Theranostics. 2024. PMID: 39346548 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

747 results

Search Page

Filters